UGC Approved Journal no 63975(19)
New UGC Peer-Reviewed Rules

ISSN: 2349-5162 | ESTD Year : 2014
Volume 13 | Issue 3 | March 2026

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 6 Issue 5
May-2019
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIRBK06018


Registration ID:
207832

Page Number

101-105

Share This Article


Jetir RMS

Title

COMPARATIVE INSILICO DOCKING STUDIES OF RUTIN AS DIABETIC INHIBITOR AGAINST PROTEIN TYROSINE PHOSPHATE

Abstract

Rutin, a bioflavonol compound was one of vital nutritional component present in many medicinal plants and exhibit a several pharmacological property. Diabetes is one of the most serious metabolic disorders across the world which affects all age groups. According to World Health Organization (WHO), more than 230 million individuals were affected worldwide by diabetes; they also expected that it will reach upto 350 million by end 2025. Currently in India more than 62 million individuals were diagnosed by diabetes, therefore there is an urgent need for the discovery of novel natural anti-diabetic drugs without any side effects. The present study was designed in order to evaluate its binding efficiency with anti-diabetic protein target protein tyrosine phosphates (PTP) through in silico studies. The function of Insulin receptor, the protein tyrosine phosphatase was to the remove the phosphate group from the tyrosine amino acid which was present in the functional region thereby decreasing the production of insulin. The crystal structure of protein tyrosine phosphate was selected as target from the protein data bank and further docking studies were performed using Argus lab software. Among the 14 protein structure of protein tyrosine phosphatase, the compound rutin exhibited significant binding energy with 2BO7 and also exhibited the better binding affinity with other protein structures. The future studies could be designed accordingly to highlight the efficiency of rutin towards drug development in the treatment of diabetes.

Key Words

Diabetes, Rutin, Protein Tyrosine Phosphates, Molecular Docking.

Cite This Article

"COMPARATIVE INSILICO DOCKING STUDIES OF RUTIN AS DIABETIC INHIBITOR AGAINST PROTEIN TYROSINE PHOSPHATE", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.6, Issue 5, page no.101-105, May-2019, Available :http://www.jetir.org/papers/JETIRBK06018.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"COMPARATIVE INSILICO DOCKING STUDIES OF RUTIN AS DIABETIC INHIBITOR AGAINST PROTEIN TYROSINE PHOSPHATE", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.6, Issue 5, page no. pp101-105, May-2019, Available at : http://www.jetir.org/papers/JETIRBK06018.pdf

Publication Details

Published Paper ID: JETIRBK06018
Registration ID: 207832
Published In: Volume 6 | Issue 5 | Year May-2019
DOI (Digital Object Identifier):
Page No: 101-105
Country: -, -, - .
Area: Engineering
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

0002934

Print This Page

Current Call For Paper

Jetir RMS